Given that PD‐1/PD‐L1 blockade immunotherapy can activate anti‐tumour immune responses, it is possible that radiotherapy combined with PD‐1/PD‐L1 blockade immunotherapy can amplify immune responses against tumours and therefore increase the occurrence of abscopal effects. This evidence concerns the gene CD274 and neoplasm.